Moreover, PD-L1 genetic copy number gain or chromosomal amplification can be responsible for PD-1 ligand overexpression, an event observed in cancers such as TNBC and squamous cell carcinoma of the vulva and cervix [116]. The gene discussed is PDCD1; the disease is cancer.